Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (381-390 of 491) with videos related to

Pageof 50
Sort By:
Hepatology Communications|September 29, 2021
Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPSLena Stockhoff, Theresa Muellner-Bucsics, Antoaneta A Markova, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 9, 2020
Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver diseaseBenedikt Simbrunner, Alexander Stadlmann, Philipp Schwabl, et al.
Journal of Hepatology|March 1, 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver diseaseKatrine Holtz Thorhauge, Georg Semmler, Stine Johansen, et al.
Scientific Reports|June 14, 2026
Characterization of liver disease regression in murine models of liver fibrosis and portal hypertensionPhilipp Königshofer, Ksenia Brusilovskaya, Benedikt S Hofer, et al.
Wiener Klinische Wochenschrift|February 5, 2026
Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensationMichael Schwarz, Caroline Schwarz, David J M Bauer, et al.
Nature Reviews. Gastroenterology & Hepatology|August 5, 2024
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2025
Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative NeoplasmsLorenz Balcar, Lina Degenfeld-Schonburg, Can Hopp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2025
Diagnostic and Clinical Implications of High Spleen-To-Liver Stiffness Ratio in MASH-A Prospective, Comparative StudyChristian Sebesta, Mathias Jachs, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2025
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver DiseaseBenedikt Simbrunner, Ida Falk Villesen, Georg Semmler, et al.
Hepatology International|May 22, 2021
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomesLukas Hartl, Mathias Jachs, Christopher Desbalmes, et al.
Pageof 50

Showing results (381-390 of 491) with videos related to

Sort By:
Pageof 50
Hepatology Communications|September 29, 2021
Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPSLena Stockhoff, Theresa Muellner-Bucsics, Antoaneta A Markova, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 9, 2020
Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver diseaseBenedikt Simbrunner, Alexander Stadlmann, Philipp Schwabl, et al.
Journal of Hepatology|March 1, 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver diseaseKatrine Holtz Thorhauge, Georg Semmler, Stine Johansen, et al.
Scientific Reports|June 14, 2026
Characterization of liver disease regression in murine models of liver fibrosis and portal hypertensionPhilipp Königshofer, Ksenia Brusilovskaya, Benedikt S Hofer, et al.
Wiener Klinische Wochenschrift|February 5, 2026
Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensationMichael Schwarz, Caroline Schwarz, David J M Bauer, et al.
Nature Reviews. Gastroenterology & Hepatology|August 5, 2024
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2025
Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative NeoplasmsLorenz Balcar, Lina Degenfeld-Schonburg, Can Hopp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2025
Diagnostic and Clinical Implications of High Spleen-To-Liver Stiffness Ratio in MASH-A Prospective, Comparative StudyChristian Sebesta, Mathias Jachs, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2025
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver DiseaseBenedikt Simbrunner, Ida Falk Villesen, Georg Semmler, et al.
Hepatology International|May 22, 2021
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomesLukas Hartl, Mathias Jachs, Christopher Desbalmes, et al.
Pageof 50